Rifampicin-protamine protocol applied for prevention of central catheter sepsis in haemodialysis.
Montagnac
R
R
Schillinger
F
F
D016470:Bacteremia / Q000209:etiology / Q000517:prevention & control*; D002405:Catheterization, Central Venous / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D006801:Humans; D011479:Protamines / Q000627:therapeutic use*; D006435:Renal Dialysis / Q000009:adverse effects*; D012293:Rifampin / Q000627:therapeutic use*
D011479:Protamines; D012293:Rifampin